With the PPA, patients with terminal illnesses would have access to drugs that provide their only hope for treatment.
When a patient receives a scary medical diagnosis, they want access to treatments and the best specialists. But for many patients facing terminal illnesses, a lengthy approval process and bureaucratic red tape are keeping them from innovative treatments that have already been proven safe and effective.
The Promising Pathway Act (PPA) would streamline the FDA’s drug approval process and give hope to patients who don’t have time to wait by allowing them to choose early access to promising treatments that could provide a higher or better quality of life.
Learn more about the PPA and how it would improve access to more treatments, innovative drugs, and biologics and give patients hope for the future.
At FGA, we don’t just talk about changing policy—we make it happen.
By partnering with FGA through a gift, you can create more policy change that returns America to a country where entrepreneurship thrives, personal responsibility is rewarded, and paychecks replace welfare checks.
